The University of Texas Health Science Center at San Antonio
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, The University of Texas Health Science Center at San Antonio sits in the top decile of US sponsors by registered trial count (#94 of 15,742 sponsors by registered trial count).
The University of Texas Health Science Center at San Antonio: 378 sponsored US clinical trials, 77 recruiting.
The University of Texas Health Science Center at San Antonio sponsors 378 registered US clinical trials on ClinicalTrials.gov, 77 of them currently recruiting, and 264 completed. 41 of these trials are in Phase 3-4 (later-stage) and 124 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 13 trials.
Top-decile sponsor footprint
The University of Texas Health Science Center at San Antonio ranks in the top decile of sponsors by registered trial count (#94 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
264 of 284 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
378 total, page 3 of 8
Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery
NCT05971173
Demineralized Bone Allograft Fibers Versus Particulate In Sinus Augmentation
NCT06173791
Erector Spinae Regional Anesthesia for Pain Control
NCT05794828
Palatal Donor Site Wound Healing Following Periodontal Plastic Surgery Using Amnion-Chorion Membrane
NCT05927714
Application of L-PRF in Periodontal Surgery
NCT06296498
Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus
NCT05867017
Assessment of Plant-based Program Using Shared Medical Appointment
NCT05889715
Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults
NCT05786521
Financial Toxicity and Quality of Life in Patients With TGCT
NCT04531709
Binge Eating Syndrome Treatment for Older Women (BESTOW)
NCT05806788
Feasibility of Positive Links for Youth Care Engagement Intervention
NCT05689515
Transcranial Direct Current Stimulation (tDCS) in Human Subjects With PTSD Receiving an Exposure-based, Behavioral Therapy
NCT05419999
Mechanisms to Reduce Mental and Physical Fatigue Following Exercise Training in Older Adults
NCT05484661
Juntos/Together Program to Build Confidence for Complex Care Tasks Among Latino Family Caregivers
NCT05582473
Combining Aerobic Exercise and Virtual Reality for Cognitive-motor Rehabilitation in PD
NCT05385497
Vertebral Marrow Attention Trial (VMAT)
NCT05248256
Blood Flow Restriction Training in Individuals Awaiting Total Knee Replacement
NCT06111690
Radiographic Changes in the Maxillary Sinus Following Closed Sinus Augmentation
NCT06296459
Remineralization of Molar Incisor Hypomineralization (MIH) With a Hydroxyapatite Toothpaste
NCT05485662
Wound Healing Following Tooth Extraction and Ridge Preservation Using DFDBA Alone in Particulate Fiber Form and in Combination With Xenograft
NCT05400213
Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer
NCT04865731
Immediate Post-Operative Anesthesia With Either Lidocaine or Bupivacaine
NCT06293807
Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting
NCT05282706
Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder
NCT05132699
Couple's Retreats for Posttraumatic Stress Disorder
NCT05274061
The Effects of a Music Intervention on Stress, Anxiety and Academic Performance on Nursing Students
NCT05590910
Effect of mTOR Inhibition & Other Metabolism Modulating Interventions on the Elderly [SubStudy Rapa & cMRI to Evaluate Cardiac Function]
NCT04742777
Radiation Therapy Plan Quality Improvement Using Ideal Theoretical Isodose Distribution
NCT04782726
Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
NCT05093517
4D CBCT and Intrafractional Imaging for the Determination of the Most Representative 4D Simulation Planning Technique for Lung SBRT Technique Patients
NCT04717804
Contingency Management for Cannabis Use for Persons With HIV
NCT04866004
Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection
NCT04818216
Metabolism of Low Carbohydrate and Ketogenic Diet
NCT05071287
Improving Adherence to EHT Among Breast Cancer Patients
NCT02850939
Topical-RAPA Use in Inflammation Reversal and Re-setting the Epigenetic Clock
NCT04608448
Safety of SP-420 in the Treatment of Transfusional Iron Overload
NCT04741542
CBD for Dental Pain
NCT04642404
Host Immune Response to Novel RNA COVID-19 Vaccination
NCT04784689
Pilot Study to Investigate the Safety and Feasibility of AntiRetroviral Therapy for Alzheimer's Disease
NCT04552795
Examining the Individual Response to a Restricted Sodium Diet in Hypertensive Patients
NCT04764253
Neurobiological Similarities of Tinnitus and PTSD
NCT05981391
The Impact of Patch Rx Technologies on Adherence to Vitamin and Trikafta Therapies in Patients With Cystic Fibrosis
NCT04684823
Effect of Ketogenic Diet on Glucose Metabolism and Energy Expenditure in Type 2 Diabetes
NCT04791787
In-person vs. Remote Wellness Support
NCT04526067
Testing the Bioavailability of Phytonutrients, Curcumin and Ursolic Acid
NCT04421716
AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer
NCT04430036
Augmenting Massed Prolonged Exposure With a Stellate Ganglion Block to Treat PTSD
NCT04302181
Effects of Creatine Supplementation in Breast Cancer Survivors
NCT04207359
Learning Skills Together Pilot Study
NCT04428034
Daily Study of Caregiving Relationships and Health
NCT04682535
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 45 |
| Phase 3 | 8 |
| Phase 4 | 33 |
Therapeutic Areas
What is open in the The University of Texas Health Science Center at San Antonio pipeline
77 recruiting of 378 indexed (20% open); 264 completed (70%).
Phase mix: 41 late (III/IV) vs 124 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas Health Science Center at San Antonio: open-pipeline peers nationwide
Peers matched on 378 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
The University of Texas Health Science Center at San Antonio sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 378 trials (± recruiting share)
- Northwell Health · 370 trials · 22% recruiting
- University of California, Irvine · 368 trials · 20% recruiting
- UNC Lineberger Comprehensive Cancer Center · 366 trials · 22% recruiting
- Roswell Park Cancer Institute · 365 trials · 16% recruiting
Sponsors near 20% open enrollment (± trial volume)
- M.D. Anderson Cancer Center · 20% recruiting · 2,692 trials
- University of Georgia · 20% recruiting · 59 trials
- University of Houston · 20% recruiting · 64 trials
- Florida International University · 20% recruiting · 89 trials
Related
What to do with this The University of Texas Health Science Center at San Antonio page
378 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Health Science Center at San Antonio or any single study.
- 77 of The University of Texas Health Science Center at San Antonio's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition The University of Texas Health Science Center at San Antonio studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
The University of Texas Health Science Center at San Antonio pipeline card: 378 registered trials from official public datasets.Report a data error.